Literature DB >> 19897715

Multiple abnormalities of myocardial insulin signaling in a porcine model of diet-induced obesity.

Jenny Lee1, Ya Xu, Li Lu, Bryan Bergman, J Wayne Leitner, Clifford Greyson, Boris Draznin, Gregory G Schwartz.   

Abstract

Heightened cardiovascular risk among patients with systemic insulin resistance is not fully explained by the extent of atherosclerosis. It is unknown whether myocardial insulin resistance accompanies systemic insulin resistance and contributes to increased cardiovascular risk. This study utilized a porcine model of diet-induced obesity to determine if myocardial insulin resistance develops in parallel with systemic insulin resistance and investigated potential mechanisms for such changes. Micropigs (n = 16) were assigned to control (low fat, no added sugars) or intervention (25% wt/wt coconut oil and 20% high-fructose corn syrup) diet for 7 mo. Intervention diet resulted in obesity, hypertension, and dyslipidemia. Systemic insulin resistance was manifest by elevated fasting glucose and insulin, abnormal response to intravenous glucose tolerance testing, and blunted skeletal muscle phosphatidylinositol-3-kinase (PI 3-kinase) activation and protein kinase B (Akt) phosphorylation in response to insulin. In myocardium, insulin-stimulated glucose uptake, PI 3-kinase activation, and Akt phosphorylation were also blunted in the intervention diet group. These findings were explained by increased myocardial content of p85alpha (regulatory subunit of PI 3-kinase), diminished association of PI 3-kinase with insulin receptor substrate (IRS)-1 in response to insulin, and increased serine-307 phosphorylation of IRS-1. Thus, in a porcine model of diet-induced obesity that recapitulates many characteristics of insulin-resistant patients, myocardial insulin resistance develops along with systemic insulin resistance and is associated with multiple abnormalities of insulin signaling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19897715      PMCID: PMC2822577          DOI: 10.1152/ajpheart.00359.2009

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  58 in total

1.  Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection.

Authors:  Sean M Davidson; Derek Hausenloy; Michael R Duchen; Derek M Yellon
Journal:  Int J Biochem Cell Biol       Date:  2005-10-21       Impact factor: 5.085

Review 2.  Insulin signal transduction in human skeletal muscle: identifying the defects in Type II diabetes.

Authors:  M Björnholm; J R Zierath
Journal:  Biochem Soc Trans       Date:  2005-04       Impact factor: 5.407

Review 3.  Involvement of novel PKC isoforms in FFA induced defects in insulin signaling.

Authors:  Debleena Dey; Dipanjan Basu; Sib Sankar Roy; Arun Bandyopadhyay; Samir Bhattacharya
Journal:  Mol Cell Endocrinol       Date:  2006-01-30       Impact factor: 4.102

4.  Nutritional upregulation of p85alpha expression is an early molecular manifestation of insulin resistance.

Authors:  M-A Cornier; D H Bessesen; I Gurevich; J W Leitner; B Draznin
Journal:  Diabetologia       Date:  2006-02-21       Impact factor: 10.122

5.  Activation of the Cbl insulin signaling pathway in cardiac muscle; dysregulation in obesity and diabetes.

Authors:  Anisha Gupte; Silvia Mora
Journal:  Biochem Biophys Res Commun       Date:  2006-02-14       Impact factor: 3.575

Review 6.  Updating the effects of fatty acids on skeletal muscle.

Authors:  Leonardo R Silveira; Jarlei Fiamoncini; Sandro M Hirabara; Joaquim Procópio; Tavane D Cambiaghi; Carlos Hermano J Pinheiro; Lúcia R Lopes; Rui Curi
Journal:  J Cell Physiol       Date:  2008-10       Impact factor: 6.384

7.  Rescuing 3T3-L1 adipocytes from insulin resistance induced by stimulation of Akt-mammalian target of rapamycin/p70 S6 kinase (S6K1) pathway and serine phosphorylation of insulin receptor substrate-1: effect of reduced expression of p85alpha subunit of phosphatidylinositol 3-kinase and S6K1 kinase.

Authors:  Rebecca Adochio; J Wayne Leitner; Reed Hedlund; Boris Draznin
Journal:  Endocrinology       Date:  2008-10-23       Impact factor: 4.736

8.  Components of metabolic syndrome and coronary artery disease in female Ossabaw swine fed excess atherogenic diet.

Authors:  Melissa C Dyson; Mouhamad Alloosh; James P Vuchetich; Eric A Mokelke; Michael Sturek
Journal:  Comp Med       Date:  2006-02       Impact factor: 0.982

Review 9.  Insulin signalling in the heart.

Authors:  Luc Bertrand; Sandrine Horman; Christophe Beauloye; Jean-Louis Vanoverschelde
Journal:  Cardiovasc Res       Date:  2008-04-05       Impact factor: 10.787

10.  Intramuscular lipid metabolism in the insulin resistance of smoking.

Authors:  Bryan C Bergman; Leigh Perreault; Devon M Hunerdosse; Mary C Koehler; Ali M Samek; Robert H Eckel
Journal:  Diabetes       Date:  2009-07-06       Impact factor: 9.461

View more
  26 in total

Review 1.  Use of metformin in diseases of aging.

Authors:  John M Miles; Andrew D Rule; Barry A Borlaug
Journal:  Curr Diab Rep       Date:  2014-06       Impact factor: 4.810

2.  Down-regulation of Insulin Receptor Substrate 1 during Hyperglycemia Induces Vascular Smooth Muscle Cell Dedifferentiation.

Authors:  Gang Xi; Christine Wai; Morris F White; David R Clemmons
Journal:  J Biol Chem       Date:  2016-12-21       Impact factor: 5.157

3.  Regulation of hepatic Na+/K+-ATPase in obese female and male rats: involvement of ERK1/2, AMPK, and Rho/ROCK.

Authors:  Julijana Stanimirovic; Milan Obradovic; Anastasija Panic; Voin Petrovic; Dragan Alavantic; Irena Melih; Esma R Isenovic
Journal:  Mol Cell Biochem       Date:  2017-08-17       Impact factor: 3.396

4.  Naturally occurring compensated insulin resistance selectively alters glucose transporters in visceral and subcutaneous adipose tissues without change in AS160 activation.

Authors:  A P Waller; K Kohler; T A Burns; M C Mudge; J K Belknap; V A Lacombe
Journal:  Biochim Biophys Acta       Date:  2011-02-23

5.  Obesity and insulin resistance induce early development of diastolic dysfunction in young female mice fed a Western diet.

Authors:  Camila Manrique; Vincent G DeMarco; Annayya R Aroor; Irina Mugerfeld; Mona Garro; Javad Habibi; Melvin R Hayden; James R Sowers
Journal:  Endocrinology       Date:  2013-07-24       Impact factor: 4.736

6.  Does resveratrol improve insulin signaling in chronically ischemic myocardium?

Authors:  Ashraf A Sabe; Nassrene Y Elmadhun; Michael P Robich; Rahul S Dalal; Frank W Sellke
Journal:  J Surg Res       Date:  2013-03-29       Impact factor: 2.192

7.  Abnormal endocrine pancreas function at birth in cystic fibrosis ferrets.

Authors:  Alicia K Olivier; Yaling Yi; Xingshen Sun; Hongshu Sui; Bo Liang; Shanming Hu; Weiliang Xie; John T Fisher; Nicholas W Keiser; Diana Lei; Weihong Zhou; Ziying Yan; Guiying Li; Turan I A Evans; David K Meyerholz; Kai Wang; Zoe A Stewart; Andrew W Norris; John F Engelhardt
Journal:  J Clin Invest       Date:  2012-09-17       Impact factor: 14.808

8.  Impairment of cardiac insulin signaling in fructose-fed ovariectomized female Wistar rats.

Authors:  Zorica Zakula; Goran Koricanac; Snezana Tepavcevic; Mojca Stojiljkovic; Tijana Milosavljevic; Esma R Isenovic
Journal:  Eur J Nutr       Date:  2011-01-01       Impact factor: 5.614

9.  Changes in cardiac Na+/K+-ATPase expression and activity in female rats fed a high-fat diet.

Authors:  Aleksandra Jovanovic; Milan Obradovic; Emina Sudar Milovanovic; Alan J Stewart; Samantha J Pitt; Dragan Alavantic; Ema Aleksic; Esma R Isenovic
Journal:  Mol Cell Biochem       Date:  2017-05-31       Impact factor: 3.396

10.  Impaired contractile recovery after low-flow myocardial ischemia in a porcine model of metabolic syndrome.

Authors:  Janice V Huang; Li Lu; Shuyu Ye; Bryan C Bergman; Genevieve C Sparagna; Mohammad Sarraf; Jane E B Reusch; Clifford R Greyson; Gregory G Schwartz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-01-18       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.